DNA methylation testing for vulvar cancer risk stratification in patients with high-grade vulvar intraepithelial neoplasia: a population-based cohort study
British Journal of Dermatology · 2025
DOI: 10.1093/bjd/ljaf302 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Nikki B Thuijs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Vulvar Neoplasms, DNA Methylation, Carcinoma in Situ. Die Arbeit nennt 36 Literaturangaben. Gefördert von: the Dutch Cancer Society.
Abstract (Originalsprache)
Background
High-grade vulvar intraepithelial neoplasia (VIN) is the precursor of vulvar cancer. The main variants are human papillomavirus (HPV)-associated high-grade squamous intraepithelial lesion (HSIL) and HPV-independent VIN, often clinically referred to as differentiated VIN (dVIN) and associated with vulvar dermatoses, usually lichen sclerosus. Surgical treatment of high-grade VIN often leads to genital deformity, impaired sexual function and reduced quality of life. To optimize clinical management, accurate biomarkers providing information on the cancer risk of high-grade VIN are needed.
Objectives
To investigate the prognostic value of a three-gene methylation marker panel and other potential risk factors for the risk of progression to cancer in patients with HSIL and dVIN.
Methods
From a population-based cohort of patients diagnosed with high-grade VIN, patients with a histopathologically confirmed diagnosis of HSIL (n = 578) and dVIN (n = 46) were selected. All lesions were tested by a three-gene methylation panel including the genes ZNF582, SST and miR124-2. The vulvar cancer risk and the prognostic value of methylation status, age, HPV genotype, wild-type vs. mutant p53 immunohistochemistry status and presence of lichen sclerosus were estimated by Kaplan–Meier and Cox regression, respectively.
Results
Vulvar cancer developed in 26 of 578 patients with HSIL (4.5%) and in 21 of 46 with dVIN (46%) within 5 years. In HSIL, positive methylation status was identified as the only prognostic factor for vulvar cancer development [hazard ratio (HR) 4.87, 95% confidence interval (CI) 1.20–21.45]. The prognostic value of methylation remained present when selecting patients who did not receive radical surgical excision as their primary treatment. In this group, the 5-year cancer risk was 7.7% in methylation-positive HSIL and 1.4% in methylation-negative HSIL (P = 0.008). In dVIN, mutant p53 status was the sole prognostic risk factor for progression to cancer (HR 7.67, 95% CI 1.78–33.08).
Conclusions
Despite wide CIs, the three-gene methylation test serves as a promising prognostic tool for cancer risk stratification in patients with vulvar HSIL. Patients with methylation-negative HSIL carry a low cancer risk, allowing for more conservative management strategies. This approach may help avoid overtreatment, reducing morbidity and improving quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands.
- Gynaecology, Netherlands Cancer Institute/Antoni Van Leeuwenhoek hospital, Amsterdam, the Netherlands.
- Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Féline O Voss
Förderung
- the Dutch Cancer Society
Zitieren
APA
Thuijs, N. B., Voss, F. O., van Beurden, M., Duin, S., de Vries, D. C., Steenbergen, R. D. M., Berkhof, J., & Bleeker, M. C. G. (2025). DNA methylation testing for vulvar cancer risk stratification in patients with high-grade vulvar intraepithelial neoplasia: a population-based cohort study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf302
Vancouver
Thuijs NB, Voss FO, van Beurden M, Duin S, de Vries DC, Steenbergen RDM, et al. DNA methylation testing for vulvar cancer risk stratification in patients with high-grade vulvar intraepithelial neoplasia: a population-based cohort study. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljaf302
BibTeX
@article{Thuijs2025,
author = {Thuijs, Nikki B and Voss, Féline O and van Beurden, Marc and Duin, Sylvia and de Vries, Dominique C and Steenbergen, Renske D M and Berkhof, Johannes and Bleeker, Maaike C G},
title = {DNA methylation testing for vulvar cancer risk stratification in patients with high-grade vulvar intraepithelial neoplasia: a population-based cohort study},
journal = {British Journal of Dermatology},
year = {2025},
doi = {10.1093/bjd/ljaf302}
}
EUVIMED